Straumann Holding AG
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 316.00 | Ssrxcp | Tgdmxqnk |
Despite Omicron and Geopolitical Headwinds, Implant Volume Shows Strong Growth at Straumann
Business Strategy and Outlook
Straumann is a global leader in dental implants, with a dominant position in the premium dental implant market and a growing share of the fragmented non-premium end of the market. The company’s brand is well established and trusted by dental professionals for its high quality and the excellent training and support offered. Furthermore, the technologies behind the company’s premium implants are supported by decades of clinical research and collaboration with academic networks. Given the pickup in demand following COVID-19 disruption to dental offices in 2021, the size of the global dental implant market was in excess of CHF 5 billion. We anticipate the market will continue to grow faster than global GDP due an aging population in premium markets, a growing middle class with disposable income in strategic growth and emerging markets, and increasing interest in dental hygiene and cosmetic procedures.